Rheumatoid Arthritis
A new clinical trial for people with Rheumatoid Arthritis.
Recruiting
Male/Female
18+ years of age
Compensation Provided
- About the Study
- The aim of this trial is to investigate whether a potential new treatment can improve symptoms in people with Rheumatoid Arthritis who have not responded to standard drugs. This medicine has not yet been approved for the treatment of Rheumatoid Arthr itis and is being investigated in clinical trials.
- What does the study involve?
- If this trial is a good fit and you would like to take part, you would be expected to participate in the study for about 10 months and attend 19 clinic visits (every 2 weeks during treatment, then every 4 weeks after the last dose).
- Who can participate?
- To be eligible you must have been diagnosed with Rheumatoid Arthritis, and be receiving treatment with at least 1 but not more than 2 of the following drugs: methotrexate, leflunomide, sulfasalazine, hydroxychloroquine or chloroquine.
- Where is the study taking place?
- The study is being conducted at our Boynton Beach office.
- Is compensation provided?
- Yes
Apply for this study
Please enter your name, a valid phone number, and a valid email address where you can be contacted.
Thank you for applying
We will contact you shortly. Please check your email for additional instructions.